Cholesgen Pharmaceutical Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $14.2M

  • Investors
  • 5

Cholesgen Pharmaceutical General Information

Description

Developer of innovative drugs designed for metabolic diseases and tumor treatment-related diseases. The company integrates the reporter gene screening system based on the target regulation mechanism, the protein small molecule interaction system, and the in vitro drug efficacy test system based on the target function in the research and development of new drugs, and builds an independent research and development platform for biochemical and cell testing to optimize drugs in an all-round way and promote them efficiently In-depth and development of drug research and development, providing medical industry users with innovative drug solutions.

Contact Information

Website
www.cholesgen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 1077 Zhangheng Road, Pudong New Area
  • Shanghai, 201103
  • China
+86 138
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • No. 1077 Zhangheng Road, Pudong New Area
  • Shanghai, 201103
  • China
+86 138

Cholesgen Pharmaceutical Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cholesgen Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A1) 18-Oct-2024 $14.2M Completed Product Development
2. Early Stage VC (Series A) 30-May-2023 Completed Product Development
1. Seed Round 07-Feb-2021 Completed Startup
To view Cholesgen Pharmaceutical’s complete valuation and funding history, request access »

Cholesgen Pharmaceutical Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 9

    Pending

  • Expiring in next 12 mo

Cholesgen Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026195058-A1 Rnai construct for inhibiting expression of usp20 gene and use thereof Pending 21-Mar-2025
WO-2026098680-A1 Rnai construct for inhibiting asgr1 gene expression and use thereof Pending 11-Nov-2024
WO-2025020191-A1 Steroid compound, preparation method therefor, and use thereof Inactive 27-Jul-2023
WO-2025020190-A1 Steroid compounds, preparation method therefor and use thereof Inactive 27-Jul-2023
EP-4530297-A1 Anti-asgr1 monoclonal antibody and use thereof Pending 25-Apr-2022 A61P3/06
To view Cholesgen Pharmaceutical’s complete patent history, request access »

Cholesgen Pharmaceutical Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
State Development and Investment Group Government Minority
Dawu Venture Capital Venture Capital Minority
Gaorong Ventures Venture Capital Minority
Wuxi AstraZeneca CICC Venture Capital Partnership Venture Capital Minority
Trinity Innovation Fund Venture Capital Minority
To view Cholesgen Pharmaceutical’s complete investors history, request access »

Ready to get started?

Request a free trial

Cholesgen Pharmaceutical FAQs

  • When was Cholesgen Pharmaceutical founded?

    Cholesgen Pharmaceutical was founded in 2021.

  • Where is Cholesgen Pharmaceutical headquartered?

    Cholesgen Pharmaceutical is headquartered in Shanghai, China.

  • What industry is Cholesgen Pharmaceutical in?

    Cholesgen Pharmaceutical’s primary industry is Drug Discovery.

  • Is Cholesgen Pharmaceutical a private or public company?

    Cholesgen Pharmaceutical is a Private company.

  • What is Cholesgen Pharmaceutical’s current revenue?

    The current revenue for Cholesgen Pharmaceutical is .

  • How much funding has Cholesgen Pharmaceutical raised over time?

    Cholesgen Pharmaceutical has raised $28.5M.

  • Who are Cholesgen Pharmaceutical’s investors?

    State Development and Investment Group, Dawu Venture Capital, Gaorong Ventures, Wuxi AstraZeneca CICC Venture Capital Partnership, and Trinity Innovation Fund have invested in Cholesgen Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process